BENEFITS OF ACLIDINIUM BROMIDE IN THE RELIEF OF COPD SYMPTOMS INCLUDING COUGH
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
The aim of the present study is to evaluate the effect of aclidinium bromide 400 μg BID
compared with placebo on COPD symptoms in a symptomatic patients population with moderate
COPD and chronic bronchitis, and particularly assess the effects in cough by using specific
tools to assess the occurrence and impact of this relevant COPD symptom.